针对三阴性乳腺癌的分子向疗法:历史,进展和未来方向
Nicholas Mai1, Nour Abuhadra1, Komal Jhaveri1
1Memorial Sloan Kettering Cancer Center, New York, NY.
Clinical breast cancer
|June 19, 2023
概括
三阴性乳腺癌 (TNBC) 缺乏有效的向疗法. 目前的研究正在探索免疫疗法和抗体-药物联合体 (ADC) 等新的方法,以改善这种侵袭性癌症亚型的结果.
科学领域:
- 在瘤学瘤学.
- 医学研究 医学研究
- 药理学 药理学是指药理学的学科.
背景情况:
- 三阴性乳腺癌 (TNBC) 是一种具有不良预后的侵袭性亚型.
- 化疗是主要的治疗方法,但有针对性的治疗方法有限.
- 免疫疗法和抗体药物合物 (ADC) 是有前途的,但分子向疗法的进展滞后.
研究的目的:
- 审查TNBC治疗的分子标.
- 讨论历史和当前的向疗法开发工作.
- 解决改善TNBC结果的有希望的进展.
主要方法:
- 对TNBC分子标和治疗剂的文献综述.
- 对针对性治疗的历史临床试验数据的分析.
- 综合关于新型治疗方式的当前研究.
主要成果:
- 在TNBC中,PARP抑制剂,PI3K通路抑制剂和EGFR抑制的有效性有限.
- 在未选择的TNBC中观察到免疫疗法和ADC的临床益处.
- PARP 抑制剂的有效性是短暂的,耐药性是一个重要的障碍.
结论:
- 尽管有挫折,但针对TNBC的向治疗研究显示出有前途.
- 需要新的治疗方法来克服当前的治疗障碍.
- 未来的TNBC治疗可能涉及免疫疗法,ADCs和AR向的组合.
更多相关视频
14:20Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
Published on: June 13, 2014
16.8K
13:19Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery
Published on: April 26, 2024
2.7K
相关概念视频
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Tumor Progression
6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K
Combination Therapies and Personalized Medicine
5.0K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.0K
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Microorganisms in Medicine and Therapeutics
72
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
72
